Acceleron Pharma Inc Profit margin

What is the Profit margin of Acceleron Pharma Inc?

The Profit margin of Acceleron Pharma Inc is -226.01%

What is the definition of Profit margin?



Profit margin is a measure of profitability and is calculated by finding the net profit as a percentage of the revenue.

lfy (last fiscal year)

Profit margin is calculated with the selling price (or revenue) taken as base times 100. It is the percentage of selling price that is turned into profit. Profit percentages are calculated to find the ratio of profit to cost of an investment. Profit margin is an indicator of a company's pricing strategies and how well it controls costs. Differences in competitive strategy and product mix cause the profit margin to vary among different companies. The profit margin is used mostly for internal comparisons. It is difficult to accurately compare the net profit ratio for different entities. Individual businesses' operating and financing arrangements vary so much that different entities are bound to have different levels of expenditure, so that comparison of one with another can have little meaning. A low profit margin indicates a low margin of safety: higher risk that a decline in sales will erase profits and result in a net loss, or a negative margin.

Profit margin of companies in the Health Care sector on NASDAQ compared to Acceleron Pharma Inc

What does Acceleron Pharma Inc do?

Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron's leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair.

Companies with profit margin similar to Acceleron Pharma Inc